Terms: = Uterine cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
82 results:
1. Comparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study.
Yoon HJ; Kwon BS; Rho HJ; Lee TH; Jeong DH; Kim KH; Suh DS; Song YJ
Medicine (Baltimore); 2024 Mar; 103(10):e37426. PubMed ID: 38457577
[TBL] [Abstract] [Full Text] [Related]
2. Whether specific genetic feature predicted immunotherapy efficacy: A case report.
Chen J; Pang L; He L; Li T; Cheng X
Medicine (Baltimore); 2024 Jan; 103(2):e36922. PubMed ID: 38215117
[TBL] [Abstract] [Full Text] [Related]
3. Managing Inflammatory Myofibroblastic Tumor of the Uterus: A Case Report and Comprehensive Review of Pathological and Therapeutic Approaches.
Ji X; Zhai P; Wang H; Yang H; Wang X
Am J Case Rep; 2023 Nov; 24():e941519. PubMed ID: 37953537
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
Mungo C; Osongo CO; Ambaka J; Omoto J; Cohen CR
Int J Cancer; 2023 Dec; 153(12):1971-1977. PubMed ID: 37715464
[TBL] [Abstract] [Full Text] [Related]
5. Factors associated with Trichomonas vaginalis infection in reproductive-aged women attending cervical screening in southeast of Brazil.
da Silva Pinto GV; Bolpet ADN; Martin LF; Moço NP; Ramos BRA; Silva MC; Duarte MTC; da Rocha Tristão A; da Silva MG; Marconi C
Braz J Infect Dis; 2023; 27(4):102794. PubMed ID: 37500061
[TBL] [Abstract] [Full Text] [Related]
6. Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors.
Dufresne A; Pissaloux D; Ngo C; Penel N; Le Cesne A; Macagno N; Vanacker H; Hénon C; Jean-Denis M; Rughoo K; Tirode F; Blay JY; Brahmi M
ESMO Open; 2023 Apr; 8(2):101202. PubMed ID: 37054503
[TBL] [Abstract] [Full Text] [Related]
7. Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review.
Murakami I; Machida H; Morisada T; Terao Y; Tabata T; Mikami M; Hirashima Y; Kobayashi Y; Baba T; Nagase S
J Gynecol Oncol; 2023 Jul; 34(4):e49. PubMed ID: 36929578
[TBL] [Abstract] [Full Text] [Related]
8. Oncologic Outcomes of Surgically Treated Cervical cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical cancer Collaborative) Working Group Study.
Aubrey C; Pond GR; Helpman L; Vicus D; Elit L; Plante M; Lau S; Kwon JS; Altman AD; Willows K; Feigenberg T; Sabourin J; Samouelian V; Bernard L; Cockburn N; Saunders NB; Piedimonte S; Teo-Fortin LA; Kim SR; Sadeq N; Jang JH; Shamiya S; Nelson G
Curr Oncol; 2023 Feb; 30(2):1977-1985. PubMed ID: 36826114
[TBL] [Abstract] [Full Text] [Related]
9. Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological images.
Zhang K; Sun K; Zhang C; Ren K; Li C; Shen L; Jing D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6075-6083. PubMed ID: 36653539
[TBL] [Abstract] [Full Text] [Related]
10. uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-alk fusions: clinicopathologic features of 4 cases and literature review.
Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y
Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188
[TBL] [Abstract] [Full Text] [Related]
11. Epidemiological Trends and Attributable Risk Burden of Cervical cancer: An Observational Study from 1990 to 2019.
Yao H; Yan C; Qiumin H; Li Z; Jiao A; Xin L; Hong L
Int J Clin Pract; 2022; 2022():3356431. PubMed ID: 36263235
[TBL] [Abstract] [Full Text] [Related]
12. The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
He Z; Chen R; Hu S; Zhang Y; Liu Y; Li C; Lv F; Xiao Z
BMC Cancer; 2022 Jul; 22(1):776. PubMed ID: 35840910
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and
Swami D; Mudaliar P; Bichu YS; Kumar Sahu V; Devarajan S; Basu S; Aich J
J Biomol Struct Dyn; 2023; 41(12):5802-5816. PubMed ID: 35818867
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
15. [Infection and distribution characteristics of HPV of middle-aged and elderly women from a certain hospital in Guangxi Zhuang Autonomous Region from 2018 to 2020].
Wei XN; Xu XY; Wang SW
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Apr; 56(4):468-473. PubMed ID: 35488545
[No Abstract] [Full Text] [Related]
16. alk Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
[TBL] [Abstract] [Full Text] [Related]
17. Inflammatory myofibroblastic tumour of an unusual presentation in the uterine cervix: a case report.
López de Sa A; Pascual A; Garcia Santos J; Mendez R; Bellon M; Ramirez M; Matute F; Del Arco C; Manzano A; Coronado P; Casado A; Marquina G
World J Surg Oncol; 2021 Nov; 19(1):331. PubMed ID: 34801049
[TBL] [Abstract] [Full Text] [Related]
18. [Immunohistochemical and molecular diagnosis of inflammatory myofibroblastic tumor of the uterus: a literature review and a clinical case].
Sanaya SZ; Matsneva IA; Redkina NA; Telezhnikova IM; Magnaeva AS; Tregubova AV; Asaturova AV; Kometova VV
Arkh Patol; 2021; 83(5):43-48. PubMed ID: 34609804
[TBL] [Abstract] [Full Text] [Related]
19. Response to lorlatinib on a patient with alk-rearranged non-small cell lung cancer harboring 1151Tins mutation with uterine metastasis.
Kobayashi T; Kanda S; Fukushima T; Noguchi T; Sekiguchi N; Koizumi T
Thorac Cancer; 2021 Aug; 12(16):2275-2278. PubMed ID: 34184417
[TBL] [Abstract] [Full Text] [Related]
20. uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
[TBL] [Abstract] [Full Text] [Related]
[Next]
